Oncology Pharmaceuticals Market Research 2024-2029, Profiles of Major Players - Bristol-Myers Squibb, Merck & Co, F. Hoffmann-La Roche, Johnson & Johnson, and AstraZeneca
31. Dezember 2024 04:01 ET
|
Research and Markets
Dublin, Dec. 31, 2024 (GLOBE NEWSWIRE) -- The "Oncology Pharmaceuticals Market" report has been added to ResearchAndMarkets.com's offering.The global market for oncology pharmaceuticals was valued...
Cancer Immunotherapy Drug Discovery Outsourcing Strategic Business Report 2024: Global Market to Reach $4 Billion by 2030, Driven by Trends in Global Expansion to Tap into Emerging Markets
02. Dezember 2024 07:32 ET
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Drug Discovery Outsourcing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
Global Cancer Immunotherapy Market to Reach $188.11 Billion by 2030, Propelled by Innovative Treatments and Rising Incidence Rates
05. Februar 2024 04:21 ET
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report...
United States Liver Cancer Therapeutics Research Report 2023: Markets, Competition, Forecast and Opportunities, 2018-2028
07. Dezember 2023 11:08 ET
|
Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "United States Liver Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
Oncology Drugs Global Market Opportunities and Strategies to 2032
25. Mai 2023 09:33 ET
|
Research and Markets
Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Oncology Drugs Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering.This report describes and...
Atypical Teratoid Rhabdoid Tumors (ATRT) Pipeline Insights Report 2023 Featuring Novartis Pharmaceuticals, Ipsen Pharma, Chimerix, Exelixis, & Takeda Pharmaceuticals
23. Mai 2023 08:58 ET
|
Research and Markets
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
$120+ Billion Worldwide Immuno-Oncology Drugs Industry to 2032: Rising Number of Cancer Cases Drives the Market
13. März 2023 12:33 ET
|
Research and Markets
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Head and Neck Cancer Therapeutics Global Market 2022: Sector to Reach $3.5 Billion by 2030 with APAC Being the Fastest Growing Region
23. Februar 2023 05:23 ET
|
Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Head And Neck Cancer Therapeutics Market Size, Share & Trends Analysis Report By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy), By...
Immunotherapy Drugs Global Market 2023: Sector to Reach $327.8 Billion by 2028 at a CAGR of 9.01%
10. Februar 2023 08:53 ET
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Immunotherapy Drugs Market by Type, Therapy Area, End User, and Region 2023-2028" report has been added to ResearchAndMarkets.com's offering.The...
Global Head And Neck Cancer Therapeutics Market Report 2022: Featuring Eli Lilly, Merck, Sanofi, Takeda Pharmaceutical & More
09. Januar 2023 07:48 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "Global Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and...